Genoox, a Palo Alto, CA and NYC-based genomic analysis company, raised $6m in funding.
The round was led by Inimiti Capital Partners and Glilot Capital Partners, with participation from a number of private investors from the genetic field.
The company intends to use the funds to expedite their genomic services.
co-founded by Amir Trabelsi and Moshe Einhorn in 2014, Genoox is a genomic analysis company that aims to help medical facilities integrate clinical genetic sequencing data into their patient workflow by providing data mining and analysis technologies. Genoox simplifis data management and interpretation, driving broader adoption of genomic information in patient treatment decisions by accelerating the collection, analysis and application of genetic sequencing data worldwide.
The company works with a variety of medical centers and pharmaceutical companies, to provide them with faster and more accurate genomic testing results.